A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide
Nesiritide is approved by Food and Drug Administration (FDA) for the treatment of patients with acute decompensated heart failure (ADHF) due its ability to rapidly reduce cardiac filling pressures and improve dyspnea. Numerous studies have shown that renal dysfunction is associated with unfavorable...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2009-09-01
|
| Series: | Pharmacy Practice |
| Subjects: | |
| Online Access: | http://www.pharmacypractice.org/vol07/03/175-180.htm |